Bank of Marin’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bank of Marin’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-4,812	Closed	-$295K	–	126
2021 Q4	$295K	Sell	4,812 -372	-7%	-$25.7K	0.2%	116
2021 Q3	$387K	Sell	5,184 -353	-6%	-$29.6K	0.28%	97
2021 Q2	$512K	Sell	5,537 -1,092	-16%	-$92.8K	0.37%	86
2021 Q1	$588K	Sell	6,629 -393	-6%	-$39K	0.47%	78
2020 Q4	$655K	Buy	7,022 +257	+4%	+$20.5K	0.55%	66
2020 Q3	$431K	Sell	6,765 -930	-12%	-$54.5K	0.44%	78
2020 Q2	$401K	Sell	7,695 -620	-7%	-$26.6K	0.46%	77
2020 Q1	$260K	Buy	+8,315	New	+$278K	0.35%	96

Other funds holding ARKG

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

MCMC

Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Bank of Marin's ARKG Position: Q1 2022 in Review

Bank of Marin sold out of ARK Genomic Revolution ETF (ARKG) in Q1 2022, closing a stake of 4,812 shares — an estimated $295K sold.

Bank of Marin first reported a position in ARKG in Q1 2020 and held it in 8 quarters. The position peaked at $655K in Q4 2020. 388 funds tracked by Wall St. Rank hold ARKG as of Q1 2022.

Bank of Marin reported no remaining ARK Genomic Revolution ETF position as of Q1 2022 after selling out during the quarter.
Bank of Marin sold 4,812 ARK Genomic Revolution ETF shares in Q1 2022, an estimated $295K.
Bank of Marin first reported a position in ARK Genomic Revolution ETF in Q1 2020 and held it in 8 quarters.
Bank of Marin's ARK Genomic Revolution ETF position peaked at $655K in Q4 2020.
388 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2022.

Based on Bank of Marin's 13F filing for Q1 2022, filed 10 May 2022.